{"id":"W4403119976","doi":"10.1200/jco.24.00055","title":"INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; McGill University Health Centre","funders":"","keywords":"Regorafenib; Medicine; Placebo; Internal medicine; Hazard ratio; Clinical endpoint; Cohort; Refractory (planetary science); Progression-free survival; Oncology; Quality of life (healthcare); Gastroenterology; Cancer; Surgery; Confidence interval; Overall survival; Clinical trial; Colorectal cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002849062,0.0001671429,0.001504838,0.000310442,0.00003961628,0.00002209384,0.0001832061,0.0001737963,0.000330655],"category_scores_gemma":[0.001628525,0.0001096538,0.0006768345,0.0003516887,0.00008850583,0.0001811243,0.0000506961,0.0009855125,0.00001106521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003325403,"about_ca_system_score_gemma":0.001620671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002323223,"about_ca_topic_score_gemma":0.00007764259,"domain_scores_codex":[0.9968015,0.0001532479,0.002176159,0.0002637669,0.000333728,0.0002716204],"domain_scores_gemma":[0.9965087,0.001687217,0.0009336429,0.0001883711,0.0003868528,0.0002952647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01234742,0.002427615,0.008256036,0.00009420765,0.001120999,0.00104397,0.0001661413,0.00001655372,0.0001000477,0.00008477067,0.06511173,0.9092305],"study_design_scores_gemma":[0.04038069,0.04339436,0.01935656,0.0002353148,0.002066031,0.00009091927,0.0008427126,0.0004221105,0.00001298756,0.0002400588,0.8928357,0.0001225979],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9604854,0.005170202,0.003486763,0.01723079,0.01040125,0.001117038,0.0000104739,0.00005324771,0.002044818],"genre_scores_gemma":[0.9837376,0.002277055,0.0024103,0.001612627,0.003378236,0.00004102532,0.000003472285,0.00003014343,0.006509544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9091079,"threshold_uncertainty_score":0.4471551,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1541743995025599,"score_gpt":0.541799323162396,"score_spread":0.387624923659836,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}